Topics
November/December 2018 | Subfocus: The Best Of Retina
A Review of All Things Retina
Looking back at some of the field's exciting developments over the past 12 months.
Michele Corry
July 31, 2026
Annexon Secures Up to $200 Million Credit Facility to Support Global Commercialization Plans
EyePoint Completes Enrollment in Phase 3 Duravyu Trials for DME Ahead of Schedule
July 30, 2026
Spanish Researchers Show Photoswitchable Drug Candidates Restore Vision-Related Behaviors in Retinal Degeneration Models
July 28, 2026
CHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Editorially independent content supported by advertising from Genentech
Free Print Subscription
Email Newsletter
Conference Calendar
